Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study

Andreas Roussidis; Christina Kalkavoura; Dimos Dimelis; Afroditi Theodorou; Ina Ioannidou; Eleytherios Mellos; Triantafyllia Mylonaki; Areti Spyropoulou; Andreas Yfantis

首页> 外文期刊>Annals of General Psychiatry >Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study

【24h】

Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study

机译：现实生活中精神分裂症门诊患者抗精神病药物治疗转换的原因和临床结果：ETOS观察性研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Patients under antipsychotic treatment for schizophrenia commonly exhibit poor adherence to treatment, high rates of treatment discontinuation, and frequent treatment changes. The ETOS study aimed to identify the reasons leading physicians to decide to switch antipsychotic treatment in outpatients with schizophrenia and to evaluate the outcome of this switch.

机译：背景技术针对精神分裂症接受抗精神病药物治疗的患者通常表现出对治疗的依从性差，高治疗中断率和频繁的治疗变更。 ETOS研究旨在确定导致医师决定对精神分裂症门诊患者进行抗精神病药物治疗的原因，并评估这种转变的结果。

著录项

来源
《Annals of General Psychiatry》 |2013年第1期|1-7|共7页
作者
Andreas Roussidis; Christina Kalkavoura; Dimos Dimelis; Afroditi Theodorou; Ina Ioannidou; Eleytherios Mellos; Triantafyllia Mylonaki; Areti Spyropoulou; Andreas Yfantis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Schizophrenia Clinical outcome Antipsychotic Switch Monotherapy;

机译：精神分裂症的临床结果抗精神病药切换单一疗法;

相似文献

外文文献
中文文献
专利

1. Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study [J] . Andreas Roussidis, Christina Kalkavoura, Dimos Dimelis, Annals of General Psychiatry . 2013,第1期

机译：现实生活中精神分裂症门诊患者抗精神病药物治疗转换的原因和临床结果：ETOS观察性研究
2. Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study. [J] . Novick D, Haro JM, Suarez D, International clinical psychopharmacology . 2008,第4期

机译：门诊精神分裂症患者更换抗精神病药物的临床后果：欧洲精神分裂症门诊患者健康结果研究的36个月结果。
3. Clinical consequences of switching from olanzapine to risperidone and vice versa in outpatients with schizophrenia: 36-month results from the worldwide schizophrenia outpatients health outcomes (W-SOHO) study [J] . Jihyung Hong, Diego Novick, Roberto Brugnoli, BMC Psychiatry . 2012,第1期

机译：门诊精神分裂症患者从奥氮平转换为利培酮，反之亦然的临床后果：全球精神分裂症门诊患者健康状况（W-SOHO）研究的36个月结果
4. Long-Term Olanzapine Treatment in Schizophrenic Outpatients: Its Effects on Their Quality of Life and Clinical Outcome [C] . Yasuo Fujii1, Ryoji Miyata1, Mitsukuni Murasaki Keio University International Symposium for Life Sciences and Medicine . 2002

机译：精神分裂症门诊患者的长期奥拉扎滨治疗：其对生命与临床结果的影响
5. The understanding of informed consent and the subjective experiences of inpatients diagnosed with schizophrenia participating in a clinical trial of antipsychotic medication: An exploratory study [D] . Torres, Randall Patricio 2004

机译：参加抗精神病药物临床试验的被诊断为精神分裂症的住院患者的知情同意和主观经验的理解：一项探索性研究
6. Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study [O] . Andreas Roussidis, Christina Kalkavoura, Dimos Dimelis, 2013

机译：现实生活中精神分裂症门诊患者抗精神病药物治疗转换的原因和临床结果：ETOS观察性研究
7. Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study [O] . Andreas Roussidis, Christina Kalkavoura, Dimos Dimelis, 2013

机译：现实生活中精神分裂症门诊患者抗精神病药物治疗转换的原因和临床结果：ETOS观察性研究

Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study

摘要

著录项

相似文献

相关主题

期刊订阅